These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37231165)

  • 1. Co-twin design in brain imaging-review on biomarkers of Alzheimer's disease.
    Varjonen A; Schwarz C; Vuoksimaa E
    Cereb Cortex; 2023 Jul; 33(14):9054-9066. PubMed ID: 37231165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of neuroinflammation with episodic memory: a [
    Lindgren N; Tuisku J; Vuoksimaa E; Helin S; Karrasch M; Marjamäki P; Kaprio J; Rinne JO
    Brain Commun; 2020; 2(1):fcaa024. PubMed ID: 32954285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Coomans EM; Tomassen J; Ossenkoppele R; Tijms BM; Lorenzini L; Ten Kate M; Collij LE; Heeman F; Rikken RM; van der Landen SM; den Hollander ME; Golla SSV; Yaqub M; Windhorst AD; Barkhof F; Scheltens P; de Geus EJC; Visser PJ; van Berckel BNM; den Braber A
    Brain; 2023 Sep; 146(9):3735-3746. PubMed ID: 36892415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.
    Weigand AJ; Bangen KJ; Thomas KR; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
    Brain Commun; 2020; 2(1):fcz046. PubMed ID: 32051933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic memory and cortical amyloid pathology: PET study in cognitively discordant twin pairs.
    Lindgren N; Kaprio J; Karjalainen T; Ekblad L; Helin S; Karrasch M; Teuho J; Rinne JO; Vuoksimaa E
    Neurobiol Aging; 2021 Dec; 108():122-132. PubMed ID: 34607247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically identical twins show comparable tau PET load and spatial distribution.
    Coomans EM; Tomassen J; Ossenkoppele R; Golla SSV; den Hollander M; Collij LE; Weltings E; van der Landen SM; Wolters EE; Windhorst AD; Barkhof F; de Geus EJC; Scheltens P; Visser PJ; van Berckel BNM; den Braber A
    Brain; 2022 Oct; 145(10):3571-3581. PubMed ID: 35022652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses.
    Rouch L; Virecoulon Giudici K; Cantet C; Guyonnet S; Delrieu J; Legrand P; Catheline D; Andrieu S; Weiner M; de Souto Barreto P; Vellas B;
    Am J Clin Nutr; 2022 Dec; 116(6):1492-1506. PubMed ID: 36253968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia.
    Brans RG; van Haren NE; van Baal GC; Schnack HG; Kahn RS; Hulshoff Pol HE
    Arch Gen Psychiatry; 2008 Nov; 65(11):1259-68. PubMed ID: 18981337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
    Salvadó G; Shekari M; Falcon C; Operto G; Milà-Alomà M; Sánchez-Benavides G; Cacciaglia R; Arenaza-Urquijo E; Niñerola-Baizán A; Perissinotti A; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Molinuevo JL; Zetterberg H; Blennow K; Suárez-Calvet M; Gispert JD;
    Brain Commun; 2022; 4(3):fcac134. PubMed ID: 35702732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.